Published in Drug Alcohol Depend on May 21, 2003
Dependence on Prescription Opioids. Dtsch Arztebl Int (2016) 2.91
Controversies in translational research: drug self-administration. Psychopharmacology (Berl) (2008) 2.56
The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters. Drug Alcohol Depend (2006) 2.30
Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy. Mayo Clin Proc (2012) 2.04
The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend (2008) 1.68
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med (2006) 1.56
Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev (2011) 1.52
Buprenorphine: a unique drug with complex pharmacology. Curr Neuropharmacol (2004) 1.51
Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci (2007) 1.47
Pressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia. Reg Anesth Pain Med (2015) 1.44
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Drug Alcohol Depend (2007) 1.28
Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology (Berl) (2006) 1.27
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug Alcohol Depend (2009) 1.13
A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. J Subst Abuse Treat (2009) 1.01
Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities. Adm Policy Ment Health (2014) 0.94
Transdermal buprenorphine in the management of persistent pain - safety aspects. Ther Clin Risk Manag (2006) 0.93
Pharmacological maintenance treatments of opiate addiction. Br J Clin Pharmacol (2014) 0.90
Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol (2011) 0.83
Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain. Drug Alcohol Depend (2010) 0.83
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Addiction (2012) 0.82
Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addict Behav (2013) 0.82
Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci (2007) 0.79
Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120. Drug Alcohol Depend (2011) 0.79
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res (2015) 0.79
Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons. Drug Alcohol Depend (2011) 0.78
Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Exp Clin Psychopharmacol (2015) 0.78
The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis. J Stud Alcohol Drugs (2015) 0.78
Depression-like effect of prenatal buprenorphine exposure in rats. PLoS One (2013) 0.77
Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners. Drug Alcohol Depend (2015) 0.77
Two cases of intranasal naloxone self-administration in opioid overdose. Subst Abus (2014) 0.77
Medication-assisted treatment for opioid addiction: methadone and buprenorphine. J Food Drug Anal (2013) 0.77
Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes. J Immunol (2015) 0.76
Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend (2013) 0.76
Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction (2017) 0.75
The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users. Pharmacol Biochem Behav (2014) 0.75
Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges. Tob Regul Sci (2016) 0.75
Targeting practitioners: A review of guidelines, training, and policy in pain management. Drug Alcohol Depend (2017) 0.75
Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system. J Pain Res (2017) 0.75
Waterpipe tobacco smoking: knowledge, attitudes, beliefs, and behavior in two U.S. samples. Nicotine Tob Res (2008) 5.45
Electronic nicotine delivery systems: a research agenda. Tob Control (2011) 4.21
Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control (2010) 4.03
Waterpipe tobacco smoking: an emerging health crisis in the United States. Am J Health Behav (2009) 3.81
Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res (2012) 3.55
Beliefs and attitudes related to narghile (waterpipe) smoking among university students in Syria. Ann Epidemiol (2004) 3.20
Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction (2014) 3.00
Characteristics of U.S. waterpipe users: a preliminary report. Nicotine Tob Res (2007) 2.94
Estimating the beginning of the waterpipe epidemic in Syria. BMC Public Health (2004) 2.85
Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res (2006) 2.75
Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction (2005) 2.57
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol (2008) 2.44
Comparison of patterns of use, beliefs, and attitudes related to waterpipe between beginning and established smokers. BMC Public Health (2005) 2.34
CO exposure, puff topography, and subjective effects in waterpipe tobacco smokers. Nicotine Tob Res (2009) 2.29
Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob Res (2010) 2.26
Are waterpipe users interested in quitting? Nicotine Tob Res (2005) 2.19
Water-pipe tobacco smoking among middle and high school students in Arizona. Pediatrics (2009) 2.12
Waterpipe smoking among U.S. university students. Nicotine Tob Res (2012) 2.02
Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine Tob Res (2002) 1.84
Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res (2009) 1.76
Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 1.62
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59
Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction (2012) 1.51
Nicotine exposure in daily waterpipe smokers and its relation to puff topography. Addict Behav (2010) 1.44
Does switching to a tobacco-free waterpipe product reduce toxicant intake? A crossover study comparing CO, NO, PAH, volatile aldehydes, "tar" and nicotine yields. Food Chem Toxicol (2012) 1.43
Patterns of water-pipe and cigarette smoking initiation in schoolchildren: Irbid longitudinal smoking study. Nicotine Tob Res (2011) 1.41
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res (2008) 1.36
Methods to assess potential reduced exposure products. Nicotine Tob Res (2005) 1.36
Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug Alcohol Depend (2011) 1.34
Outcomes and adherence in Syria's first smoking cessation trial. Am J Health Behav (2007) 1.31
Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine Tob Res (2004) 1.24
Extent of exposure to environmental tobacco smoke (ETS) and its dose-response relation to respiratory health among adults. Respir Res (2005) 1.24
Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol (2007) 1.23
Dependence on tobacco and nicotine products: a case for product-specific assessment. Nicotine Tob Res (2012) 1.22
Smoking topography in response to denicotinized and high-yield nicotine cigarettes in adolescent smokers. J Adolesc Health (2006) 1.22
Comparative analysis of waterpipe and cigarette suppression of abstinence and craving symptoms. Addict Behav (2011) 1.21
Waterpipe-associated particulate matter emissions. Nicotine Tob Res (2008) 1.20
Water pipe tobacco smoking among university students in Jordan. Nicotine Tob Res (2010) 1.18
Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology. Nicotine Tob Res (2008) 1.18
Affecting perceptions of harm and addiction among college waterpipe tobacco smokers. Nicotine Tob Res (2011) 1.12
Waterpipe tobacco products: nicotine labelling versus nicotine delivery. Tob Control (2011) 1.12
Science and electronic cigarettes: current data, future needs. J Addict Med (2014) 1.11
High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl) (2002) 1.09
Evaluating oral noncombustible potential-reduced exposure products for smokers. Nicotine Tob Res (2010) 1.08
Cigar use misreporting among youth: data from the 2009 Youth Tobacco Survey, Virginia. Prev Chronic Dis (2012) 1.08
Indoor air quality in Virginia waterpipe cafes. Tob Control (2012) 1.05
Acute toxicant exposure and cardiac autonomic dysfunction from smoking a single narghile waterpipe with tobacco and with a "healthy" tobacco-free alternative. Toxicol Lett (2012) 1.05
Non-cigarette tobacco use among women and adverse pregnancy outcomes. Acta Obstet Gynecol Scand (2010) 1.03
Characterizing early cigarette use episodes in novice smokers. Addict Behav (2007) 1.03
Patterns of alternative tobacco use among adolescent cigarette smokers. Drug Alcohol Depend (2011) 1.02
Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev (2015) 1.02
Acute effects of cigarillo smoking. Nicotine Tob Res (2011) 1.00
The effects of nicotine on attention and working memory in never-smokers. Psychol Addict Behav (2005) 0.96
Design, baseline results of Irbid longitudinal, school-based smoking study. Am J Health Behav (2011) 0.94
Trends in alternative tobacco use among light, moderate, and heavy smokers in adolescence, 1999-2009. Addict Behav (2012) 0.94
A multiyear survey of waterpipe and cigarette smoking on a US university campus. J Am Coll Health (2012) 0.94
Acute exposure to waterpipe tobacco smoke induces changes in the oxidative and inflammatory markers in mouse lung. Inhal Toxicol (2012) 0.93
The Syrian Center for Tobacco Studies: a model of international partnership for the creation of sustainable research capacity in developing countries. Promot Educ (2004) 0.90
The acute effects of waterpipe smoking on lung function and exercise capacity in a pilot study of healthy participants. Inhal Toxicol (2013) 0.87
Fear reactivity to bodily sensations among heavy smokers and nonsmokers. Exp Clin Psychopharmacol (2008) 0.86
Waterpipes and electronic cigarettes: increasing prevalence and expanding science. Chem Res Toxicol (2014) 0.86
An observational study of group waterpipe use in a natural environment. Nicotine Tob Res (2013) 0.85
How to freak a Black & Mild: a multi-study analysis of YouTube videos illustrating cigar product modification. Health Educ Res (2013) 0.84
Comparison of tobacco-containing and tobacco-free waterpipe products: effects on human alveolar cells. Nicotine Tob Res (2013) 0.84
Measuring exposure to environmental tobacco smoke (ETS): a developing country's perspective. Prev Med (2006) 0.84
Exposure of pregnant women to waterpipe and cigarette smoke. Nicotine Tob Res (2012) 0.84
Electronic cigarettes: a review of safety and clinical issues. J Addict Med (2014) 0.84
A multiple indicators and multiple causes model of alternative tobacco use. Am J Health Behav (2013) 0.83
Central and peripheral cardiovascular changes immediately after waterpipe smoking. Inhal Toxicol (2014) 0.83
Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers. Exp Clin Psychopharmacol (2011) 0.82
CO exposure and puff topography are associated with Lebanese waterpipe dependence scale score. Nicotine Tob Res (2013) 0.82
Caffeine's influence on nicotine's effects in nonsmokers. Am J Health Behav (2007) 0.82
Recent advances in nicotine and tobacco research. Ninth SRNT annual meeting. New Orleans, Louisiana, USA. 19-22 February 2003. Nicotine Tob Res (2003) 0.77